A miRNA signature in leukocytes from sporadic amyotrophic lateral sclerosis

Gene

Volumn 508, Issue 1, 2012, Pages 35-40

  De Felice, Bruna ^a   Guida, Marco ^b   Guida, Maurizio ^c   Coppola, Cinzia ^a,d   De Mieri, Giovanna ^a   Cotrufo, Roberto ^a,d  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c UNIVERSITY OF SALERNO   (Italy)

^d Regional Interuniversity Center for Research in Neuroscience (CIRN) Naples   (Italy)

Author keywords

Leukocytes; Microarray; MicroRNAs; SALS

Indexed keywords

MICRORNA; MICRORNA 338 3P; SMALL UNTRANSLATED RNA; UNCLASSIFIED DRUG;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; LEUKOCYTE; MALE; MICROARRAY ANALYSIS; NERVOUS SYSTEM; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SPORADICAMYOTROPHIC LATERAL SCLEROSIS; UPREGULATION; VALIDATION PROCESS;

AGED; AMYOTROPHIC LATERAL SCLEROSIS; BIOLOGICAL MARKERS; FEMALE; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION TO DISEASE; GLUTAMATE PLASMA MEMBRANE TRANSPORT PROTEINS; HUMANS; LEUKOCYTES; MALE; MICRORNAS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84865536102     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.07.058     Document Type: Article

References (40)

1. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
2. Bilen J., Liu N., Burnett B.G., Pittman R.N., Bonini N.M. MicroRNA pathways modulate polyglutamine-induced neurodegeneration. Mol. Cell. 2006, 24:157-163.
3. Bissels U., et al. Absolute quantification of microRNAs by using a universal reference. RNA 2009, 15:2375-2384.
4. Borovecki F., et al. Genome-wide expression profiling of human blood reveals biomarkers for Huntington's disease. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:11023-11028.
5. Fleige S., Pfaffi M.W. RNA integrity and the effect on the real-time qRT-PCR performance. Mol. Aspects Med. 2006, 27:126-139.
6. Gaughwin P.M., Ciesla M., Lahiri N., Tabrizi S.J., Brundin P., Björkqvist M. Hsa-miR-34b is a plasma-stable microRNA that is elevated in pre-manifest Huntington's disease. Hum. Mol. Genet. 2011, 20:2225-2237.
7. Hebert S.S., De Strooper B. Alterations of the microRNA network cause neurodegenerative disease. Trends Neurosci. 2009, 32:199-206.
8. Huettl R.E., Soellner H., Bianchi E., Novitch B.G., Huber A.B. Npn-1 contributes to axon-axon interactions that differentially control sensory and motor innervation of the limb. PLoS Biol. 2011, 9:e1001020.
9. Kerjan G., et al. The transmembrane semaphorin Sema6A controls cerebellar granule cell migration. Nat. Neurosci. 2005, 8:1516-1524.
10. Kim J., et al. Identification of many microRNAs that copurify with polyribosomes in mammalian neurons. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:360-365.
11. Kocerha J., Kauppinen S., Wahlestedt C. microRNAs in CNS disorders. Neuromolecular Med. 2009, 11:162-172.
12. Landgraf P., et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 2007, 129:1401-1414.
13. Lederer C.W., Torrisi A., Pantelidou M., Santama N., Cavallaro S. Pathways and genes differentially expressed in the motor cortex of patients with sporadic amyotrophic lateral sclerosis. BMC Genomics 2007, 23:8-26.
14. Li D., et al. Grade-specific expression profiles of miRNAs/mRNAs and docking study in human grade I-III astrocytomas. OMICS 2011, 15(10):673-682.
15. Lu M., et al. An analysis of human microRNA and disease associations. PLoS One 2008, 3(10):e3420.
16. Lukiw W.J., Pogue A.I. Induction of specific micro RNA (miRNA) species by ROS-generating metal sulfates in primary human brain cells. J. Inorg. Biochem. 2007, 101:1265-1269.
17. Maes O.C., Xu S., Yu B., Chertkow H.M., Wang E., Schipper H.M. Transcriptional profiling of Alzheimer blood mononuclear cells by microarray. Neurobiol. Aging 2007, 28:1795-1809.
18. Malzkorn B., et al. Identification and functional characterization of microRNAs involved in the malignant progression of gliomas. Brain Pathol. 2010, 20:539-550.
19. Maragakis N.J., Dykes-Hoberg M., Rothstein J.D. Altered expression of the glutamate transporter EAAT2b in neurological disease. Ann. Neurol. 2004, 55:469-477.
20. Mendes N.D., Freitas A.T., Sagot M.F. Current tools for the identification of miRNA genes and their targets. Nucleic Acids Res. 2009, 37:2419-2433.
21. Miska E.A., et al. Microarray analysis of microRNA expression in the developing mammalian brain. Genome Biol. 2004, 5:R68.
22. Mraz M., Malinova K., Mayer J., Pospisilova S. MicroRNA isolation and stability in stored RNA samples. Biochem. Biophys. Res. Commun. 2009, 390:1-4.
23. Nan Y., et al. MiRNA-451 plays a role as tumor suppressor in human glioma cells. Brain Res. 2010, 1359:14-21.
24. Nelson P.T., Wang W.X., Rajeev B.W. MicroRNAs(miRNAs) in neurodegenerative diseases. Brain Pathol. 2008, 18:130-138.
25. Nishimura Y., et al. Genome-wide expression profiling of lymphoblastoid cell lines distinguishes different forms of autism and reveals shared pathways. Hum. Mol. Genet. 2007, 16:1682-1698.
26. Pantelidou M., Zographos S.E., Lederer C.W., Kyriakides T., Pfaffl M.W., Santama N. Differential expression of molecular motors in the motor cortex of sporadic ALS. Neurobiol. Dis. 2007, 26:577-589.
27. Rothstein J.D., et al. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann. Neurol. 1995, 38:73-84.
28. Rünker A.E., Little G.E., Suto F., Fujisawa H., Mitchell K.J. Semaphorin-6A controls guidance of corticospinal tract axons at multiple choice points. Neural Dev. 2008, 8:3-34.
29. Santarelli D.M., Beveridge N.J., Tooney P.A., Cairns M.J. Upregulation of dicer and microRNA expression in the dorsolateral prefrontal cortex Brodmann area 46 in schizophrenia. Biol. Psychiatry 2011, 69:180-187.
30. Saris C.G., et al. Weighted gene co-expression network analysis of the peripheral blood from amyotrophic lateral sclerosis patients. BMC Genomics 2009, 27:10-405.
31. Schaefer A., et al. Cerebellar neurodegeneration in the absence of microRNAs. J. Exp. Med. 2007, 204:1553-1558.
32. Schymick J.C., et al. Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data. Lancet Neurol. 2007, 6:322-328.
33. Sethi P., Lukiw W.J. Micro-RNA abundance and stability in human brain: specific alterations in Alzheimer's disease temporal lobe neocortex. Neurosci. Lett. 2009, 459:100-104.
34. Shioya M., et al. Aberrant microRNA expression in the brains of neurodegenerative diseases: miR-29a decreased in Alzheimer disease brains targets neurone navigator 3. Neuropathol. Appl. Neurobiol. 2010, 36:320-330.
35. Shuib S., et al. Microarray based analysis of 3p25-p26 deletions (3p- syndrome). Am. J. Med. Genet. 2009, 149A:2099-2105.
36. St Laurent G., Wahlestedt C. Noncoding RNAs: couplers of analog and digital information in nervous system function?. Trends Neurosci. 2007, 30:612-621.
37. Te J.L., et al. Identification of unique microRNA signature associated with lupus nephritis. PLoS One 2010, 5(5):e10344.
38. Wang W.X., et al. The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. J. Neurosci. 2008, 28:1213-1223.
39. Weinberg M.S., Wood M.J.A. Short non-coding RNA biology and neurodegenerative disorders: novel disease targets and therapeutics. Hum. Mol. Genet. 2009, 18:27-39.
40. Williams A.H., et al. MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice. Science 2009, 326:1549-1554.